Akebia Therapeutics | AKBA - 贷款资金



金融业
股票价格
USD
资产
USD 349.66M
现金及等价物
USD 155.55M
销售成本
USD 10.34M
流动资产
USD 229.55M
流动负债
USD 160.87M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 25.02M
销售毛利
USD 47.28M
债务利息支出
349.66M
贷款资金
USD 24.75M
市值
USD 182.4M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 13.02M
贸易债权人
USD 9.42M
应收帐款人
USD 47.03M


贷款资金 更改 日
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Akebia Therapeutics USD 24.75M 11.64M 2026-06
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
Amgen USD 51.86B 27M 2026-06
Ardelyx USD 203.52M 683K 2026-03
Astellas Pharma JPY 320B 0 2026-06
AstraZeneca USD 26.01B 46M 2026-06
Bayer EUR 31.16B 480M 2026-06
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
Celltrion KRW 411.27B 998.23M 2026-03
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Fresenius Medical Care EUR 5.82B 83.04M 2026-06
GlaxoSmithKline GBP 13.95B 65M 2026-06
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
J&J USD 37.34B 183M 2026-06
Kangmei Pharma CNY 67.35M 1.22M 2026-06
Karyopharm Therapeutics USD 264.49M 13.73M 2026-03
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Lexicon Pharmaceuticals USD 49.68M 276K 2026-03
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Moderna USD 597M 6M 2026-06
Nektar Therapeutics USD 60.27M 2.89M 2026-03
Organigram Holdings CAD 60.76M 1.77M 2026-03
Ovoca Bio EUR 0 0 2021-06
Pharma Mar EUR 32.13M 1.04M 2026-06
Prothena USD 0 0 2024-12
PTC Therapeutics USD 535.52M 248.58M 2026-06
Qiagen NV USD 1.63B 19.45M 2026-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Sanofi EUR 14.65B 806M 2026-06
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
Sartorius EUR 3.65B 311.1M 2026-06
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Tectonic Therapeutic USD 17K 26K 2026-03
Tilray USD 268.59M 3.82M 2025-09
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12
Zealand Pharma A/S 307M 76.14M 2026-03
Zz Pientze Pharmaceu CNY 172.8M 9.49M 2026-06